logo
logo
Sign in

COVID 19 Impact on Immortalized Cell Line Market Segmentation, Growth Potential, Strategic Assessment, Technological Advancement

avatar
Sapana Supekar
COVID 19 Impact on Immortalized Cell Line Market Segmentation, Growth Potential, Strategic Assessment, Technological Advancement

Immortalized cell lines are tumorous cells which undergo multiplication or have been artificially created to be cultured continuously over generations. These cells are grown for research purposes or for development of vaccines. The global immortalized cell line market report by Market Research Future (MRFR) contains useful insights, segmental analysis, and profiles of key industry leaders as well as their strategies for the period between 2017 and 2023.

Immortalized Cell Line Market Overview

The global immortalized cell line market is slated to display a CAGR of 9.3% from 2017 to 2023 (forecast period) to touch a valuation of USD 4,105.62 million by 2023. Large application of cell lines in pharmaceutical and biopharmaceutical sectors are expected to drive market growth. The large scope in organ transplantation, tissue culture, and the large patient pool are major drivers of the market. High demand for organs due to low levels of success in surgeries can bode well for immortalized cell lines. Management of cell lines can ensure the success of future experiments and expedite research and development.

Development of novel drugs are likely to spur the global immortalized cell line market growth. For instance, Onconeutics received approval for the use of ONC201 by the U.S. Food and Drug Administration (FDA) in 2018 for the treatment of abnormal malignant growths. The drug can be used to target the Caseinolytic Mitochondrial Matrix Peptidase Proteolytic (ClpP), a protease which can cause apoptosis in cancerous cells. It has been run on cell lines of various types of cancers with a degree of success and will be used in targeted therapies in the near future.

But prevention of infections on cell strains and high costs of equipment can act as restraints against market growth.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/751

Immortalized Cell Line Market  Segmentation

The global immortalized cell line market has been segmented into method, application, and end user.

Based on the method, the global market has been segmented into virus induction, hTERT expression, inactivation of tumor suppression genes, and others. The virus induction segment is further divided into EBV genes, SV40 T antigen, HPV-16 E6/6 gene, and others. The hTERT expression segment is sub-segmented into P53 and Myc T58A.

The global immortalized cell line market, based on application, is segmented into diagnostics, drug discovery, vaccine production, tissue engineering and regenerative medicine, and others.

Based on end user, the global market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), and research laboratories. The pharmaceutical and biopharmaceutical companies segment accounted for a market value of USD 1,323.79 million in 2017.

Immortalized Cell Line Market Regional Analysis

Asia Pacific (APAC), the Americas, Europe, and the Middle East & Africa (MEA) are the regions discussed with respect to the market report.

The Americas accounted for 38.1% market share in 2017. It can dominate the global market till the end of the forecast period due to strong funding in research and development, presence of various pharmaceutical and biopharmaceutical sectors, and large prevalence of cancers.

The European region holds the second position after the Americas due to ample government support and availability of sophisticated technology. On the other hand, the APAC region can enjoy tremendous growth due to influx of wherewithal in research and development by public and private companies. The large patient pool and awareness in the healthcare sector has led to various top players making a base in the region.

Immortalized Cell Line Market Competition Outlook

European Collection of Authenticated Cell Cultures (ECACC), Corning Incorporated, WuXi App Tec, ATCC (American Type Culture Collection Inc.), Valneva, Lonza Group, AG, Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Selexis SA, and others are noteworthy participants of the global influenza vaccination market.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/immortalized-cell-line-market-751

Immortalized Cell Line Industry News

The Cytomat 2 C-LiN Series Automated Incubator by Thermo Scientific can sustain cell lines for a longer period for observation of their behavior with relation to cancer and testing vaccines against novel diseases.

collect
0
avatar
Sapana Supekar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more